Biogen Inc. (BIIB)

Trade BIIB now with
8/2/2021 7:40:04 AM Biogen Announces Results From Phase 3b NOVA Study Evaluating Natalizumab In Relapsing-Remitting Multiple Sclerosis
7/22/2021 8:00:33 AM Biogen Inc. (BIIB) Has Raised Its FY21 Revenue Estimate To $10.65 - $10.85 Bln From $10.45 - $10.75 Bln
7/22/2021 7:12:54 AM Biogen Q2 GAAP EPS $2.99; Non-GAAP EPS $5.68
7/21/2021 8:04:33 AM Mirimus, Biogen To Develop RNAi-Based Therapeutics For Neurological Disease Indications
6/29/2021 9:05:20 AM Enel X Supporting Biogen In Its Goal To Achieve Fleet Electrification Of Over 1,000 Vehicles In North America By 2025
6/17/2021 7:37:44 AM Biogen Doses First Patient In Phase 3 Study Evaluating Efficacy And Safety Of BIIB059 In Systemic Lupus Erythematosus
6/10/2021 8:00:12 AM Biogen Announce New Research Supporting Development Of Investigational Higher Dose Of SPINRAZA